about
Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBATCystinuria caused by mutations in rBAT, a gene involved in the transport of cystineA microRNA code for prostate cancer metastasis.Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial.Guidelines on urolithiasis.Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma.2007 guideline for the management of ureteral calculi.PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experienceStatus of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters.Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex.Perioperative changes in pro and anticoagulant factors in prostate cancer patients undergoing laparoscopic and robotic radical prostatectomy with different anaesthetic techniques.AMBRA1 and SQSTM1 expression pattern in prostate cancer.Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical cystectomy: preliminary results.Enhanced expression of LINE-1-encoded ORF2 protein in early stages of colon and prostate transformationEndothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancerCollecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.How to use a clinical practice guideline.Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.Zero-ischemia minimally invasive partial nephrectomy.¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.Prostatic capsule and seminal vesicle-sparing cystectomy: improved functional results, inferior oncologic outcome.'Zero ischaemia', sutureless laparoscopic partial nephrectomy for renal tumours with a low nephrometry score.Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients.Robotic Level III Inferior Vena Cava Tumor Thrombectomy: Initial Series.Ureterocystoneostomy in urinary tuberculosis: a personal technique.Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy.Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma.Preoperative superselective transarterial embolization in laparoscopic partial nephrectomy: technique, oncologic, and functional outcomes.Management of hemorrhage after percutaneous renal surgery.Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification.Single-setting laparoscopic approach to synchronous urologic tumors.Early and late urodynamic assessment of Padua ileal bladder.Risk assessment of stone formation in stapled orthotopic ileal neobladder.Role of calcitonin in calcic calculosis.Nephrocutaneous fistula following extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy.Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer.Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens.Biological and clinical implication of cellular DNA content in renal cell carcinomas.
P50
Q22010508-E013508D-8E60-4BC1-99D4-10D91E04D039Q24316503-D4AB0816-3892-4BE3-B62A-25E30712018CQ27310006-50D5DE7F-1A6D-40DD-8810-DBDA483E1AB1Q33396809-F9AF71CE-2342-4806-8738-3085F9FBCEC5Q34442551-E700FD10-8E0D-4378-B57F-72ADA235557CQ34478021-50F7571C-1CEC-4CBE-8060-1D576DFE466FQ34712223-99D79D2D-9068-46D7-9615-B5E937036EB1Q35074229-017F4A00-8E51-4DAF-93E4-C92B8EA2375CQ35588461-78656E41-9661-4A25-869F-8B48ED9996B4Q35595690-C2BA6D5D-4D1D-41DA-AD09-2D6989F7A79AQ35605876-53DC6435-485E-45FC-AC83-0404C50F2B03Q36149486-DE6A539E-FE76-495E-B619-19F499252EF6Q36624367-BFE7834A-8B8C-4E69-BEE5-2FE7760684AFQ36782347-B5B41BCA-5AEC-477B-B7A1-F98D62241F2BQ37170747-6377F630-E923-41A7-A2D7-8AA622CDA249Q37327370-3F6FD623-B755-4907-9A52-833B571E5C07Q37351467-69A156F1-B9F6-4B42-BBCD-D810DB6D15B5Q37397597-4FE3B296-709C-4D51-ADAD-ACE4A840BE96Q38124767-28890D53-4025-4505-B26F-703C6C03A36AQ38236058-9BE7D550-F347-4012-A75F-42C1BAD5DDD9Q39840990-46C7A121-0DF8-460F-9666-1D44B3687D3DQ40302417-BC3D4772-A089-4107-AABF-B2EA7D7C60D0Q40856711-E15541C1-FB90-4858-8A96-BA1E73551599Q41095683-01917863-C81A-4990-A8E8-911A28AEB5E2Q41565705-2EDF0DCF-F686-4633-B95A-3FF52A038255Q41647263-DDF1A2F0-8E39-49A9-A374-572837120E19Q42491575-D604314D-CD11-485C-9986-AB6F41763E66Q42602539-3EF4274A-34E1-41F5-B6B6-29F6A3A1BAA4Q42631206-61C4B785-8003-4F41-A7FE-A5D66F207AA0Q43557849-E0340AAC-4834-4C38-9B78-CD2536E10863Q44142928-782CE3E9-8E3E-460B-9634-2D217BFF7E57Q44190000-C59601A4-4127-4F33-BFF7-5EFC880228A4Q44220388-E3969687-CC15-423D-ACA5-E479A4B62C99Q44634559-34616B21-514A-430D-9AB4-873E184DCE97Q45021327-0333CA79-808A-42BC-8F58-1C638AB83E64Q45061429-A0828EAE-381F-4584-93AD-CF82E089509EQ45083997-85A9C693-F071-4D48-9929-7C933B056492Q45754869-5703A521-8ABB-4D31-A1AD-3C57B89EE63DQ45857886-DFF875E7-A8D9-4291-AABF-4ED730F625DFQ45926692-A3F6F371-28D1-45E4-9E89-176EC5F696B6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michele Gallucci
@ast
Michele Gallucci
@en
Michele Gallucci
@es
Michele Gallucci
@nl
Michele Gallucci
@sl
type
label
Michele Gallucci
@ast
Michele Gallucci
@en
Michele Gallucci
@es
Michele Gallucci
@nl
Michele Gallucci
@sl
prefLabel
Michele Gallucci
@ast
Michele Gallucci
@en
Michele Gallucci
@es
Michele Gallucci
@nl
Michele Gallucci
@sl
P1053
K-9600-2016
P106
P1153
56246788800
P31
P3829
P496
0000-0002-3637-6531